A guide to scientific due diligence: How to set up an efficient process Part 2

Dr. Diane Seimetz | Principal Consultant, Senior Director
DD_homepage.png

by Dr. Diane Seimetz

When being asked “What is a scientific due diligence?”, what would you respond? Would you have a straightforward and simple definition at hand? If not, you may want to consider our definition: Due diligence is making sure you get what you expect. This sounds simple, yet the process can be a daunting prospect. In particular for those companies where the due diligence has to run in parallel to the day-to-day drug development business. It is therefore essential to set up an efficient process. We have been involved in numerous due diligence projects over the past 20 years. This includes assets with a value in the upper triple-digit million range.

Click here to read more about Diane’s approach on Due Diligence and her workshop at this years Pharma MBA event.

Start a conversation today

Socials:








    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more